Patent · US Active

Peptides for the treatment of malignant proliferative diseases

US10570174B2 · kind B2 · utility

0Cited by

3References

20Claims

0Family size

Assignee

YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. · IL

Inventor

Uri Wormser · Jerusalem, IL

Key dates

Filing date	Feb 7, 2016
Grant date	Feb 25, 2020
Priority date	—
Expiry date	Feb 7, 2036

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Synthetic peptides containing chemical modifications having anti-tumor properties are provided. Further provided are pharmaceutical compositions including the peptides and use thereof for treating proliferative and neoplastic diseases such as cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.